论文部分内容阅读
作者综合了317例初诊非何杰金淋巴瘤(NHL)的病例资料。其来源于1982年至1988年间美国内布拉斯加淋巴瘤研究中心的化疗资料。其中54例低度恶性,180例中度恶性,76例高度恶性,7例未分型。大多处临床Ⅲ期或Ⅳ期,初诊时均作骨髓活检,涂片细胞学检查及外周血检查。结果:①本组63％至少有一项血细胞计数异常,贫血120例(为42％),白细胞减少18例(6％),血小板减少29例(13％),白细胞增多73例(26％),血小板增多33例(14％),其贫血和NHL恶性程度相关;高度恶性伴贫血51％(平均Hb12.3g/dl),中
The authors combined 317 cases of newly diagnosed non-Hodgkin’s lymphoma (NHL) case data. It is based on chemotherapy data from the Nebraska Lymphoma Research Center from 1982 to 1988. Of these, 54 were low-grade, 180 were moderately malignant, 76 were highly malignant and 7 were non-typed. Most of the clinical stage Ⅲ or Ⅳ, when the first visit were made of bone marrow biopsy, smear cytology and peripheral blood tests. Results: ① There was at least one abnormal blood cell count in 63% of the patients with anemia in 120 cases (42%), leukopenia in 18 cases (6%), thrombocytopenia in 29 cases (13%), leukocytosis in 73 cases (26%), Thrombocythemia in 33 patients (14%), the anemia and NHL malignancy related; high degree of malignancy with anemia 51% (average Hb12.3g / dl), medium